Pre-Impressions of the Third COVID-19 Vaccination among Medical Staff: A Text Mining-Based Survey

The aim of this study was to investigate the pre-impressions of the third Coronavirus disease 2019 (COVID-19) vaccination among Japanese medical staff using quantitative analysis. Among 413 medical staff, 260 (60 men and 200 women) aged 40.4 ± 12.3 years were enrolled in this cross-sectional study....

Full description

Saved in:
Bibliographic Details
Published inVaccines Vol. 10; no. 6; p. 856
Main Authors Mori, Yoshiro, Miyatake, Nobuyuki, Suzuki, Hiromi, Mori, Yuka, Okada, Setsuo, Tanimoto, Kiyotaka
Format Journal Article
LanguageEnglish
Published Basel MDPI AG 26.05.2022
MDPI
Subjects
Age groups
Communication
Coronaviruses
COVID-19
COVID-19 vaccines
Data mining
Disease transmission
Hospitals
Influenza
Job titles
Medical personnel
Medicine
Nurses
Pregnancy
Public health
Questionnaires
R
Side effects
Software
text-mining
third COVID-19 vaccination
Underserved populations
Vaccination
Viral diseases
Japan
Online AccessGet full text
ISSN2076-393X
2076-393X
DOI10.3390/vaccines10060856

Cover

Abstract The aim of this study was to investigate the pre-impressions of the third Coronavirus disease 2019 (COVID-19) vaccination among Japanese medical staff using quantitative analysis. Among 413 medical staff, 260 (60 men and 200 women) aged 40.4 ± 12.3 years were enrolled in this cross-sectional study. Pre-impressions of the third COVID-19 vaccination were analyzed using the text-mining analysis software, KH coder. Among 260 subjects, 242 (93.1%) agreed to the third vaccination, with the rate being lower among subjects in their 30s (87.3%) than those in the other age groups. The word “side effects” was characteristic of subjects in their 20s and nurses, and “pregnancy” of those in their 30s and administrative staff. Pre-impressions of the third COVID-19 vaccination varied among age groups and different professions. The results obtained provide useful information for promoting the third COVID-19 vaccination to Japanese adults.
AbstractList The aim of this study was to investigate the pre-impressions of the third Coronavirus disease 2019 (COVID-19) vaccination among Japanese medical staff using quantitative analysis. Among 413 medical staff, 260 (60 men and 200 women) aged 40.4 ± 12.3 years were enrolled in this cross-sectional study. Pre-impressions of the third COVID-19 vaccination were analyzed using the text-mining analysis software, KH coder. Among 260 subjects, 242 (93.1%) agreed to the third vaccination, with the rate being lower among subjects in their 30s (87.3%) than those in the other age groups. The word “side effects” was characteristic of subjects in their 20s and nurses, and “pregnancy” of those in their 30s and administrative staff. Pre-impressions of the third COVID-19 vaccination varied among age groups and different professions. The results obtained provide useful information for promoting the third COVID-19 vaccination to Japanese adults.
The aim of this study was to investigate the pre-impressions of the third Coronavirus disease 2019 (COVID-19) vaccination among Japanese medical staff using quantitative analysis. Among 413 medical staff, 260 (60 men and 200 women) aged 40.4 ± 12.3 years were enrolled in this cross-sectional study. Pre-impressions of the third COVID-19 vaccination were analyzed using the text-mining analysis software, KH coder. Among 260 subjects, 242 (93.1%) agreed to the third vaccination, with the rate being lower among subjects in their 30s (87.3%) than those in the other age groups. The word "side effects" was characteristic of subjects in their 20s and nurses, and "pregnancy" of those in their 30s and administrative staff. Pre-impressions of the third COVID-19 vaccination varied among age groups and different professions. The results obtained provide useful information for promoting the third COVID-19 vaccination to Japanese adults.The aim of this study was to investigate the pre-impressions of the third Coronavirus disease 2019 (COVID-19) vaccination among Japanese medical staff using quantitative analysis. Among 413 medical staff, 260 (60 men and 200 women) aged 40.4 ± 12.3 years were enrolled in this cross-sectional study. Pre-impressions of the third COVID-19 vaccination were analyzed using the text-mining analysis software, KH coder. Among 260 subjects, 242 (93.1%) agreed to the third vaccination, with the rate being lower among subjects in their 30s (87.3%) than those in the other age groups. The word "side effects" was characteristic of subjects in their 20s and nurses, and "pregnancy" of those in their 30s and administrative staff. Pre-impressions of the third COVID-19 vaccination varied among age groups and different professions. The results obtained provide useful information for promoting the third COVID-19 vaccination to Japanese adults.
Author Suzuki, Hiromi
Okada, Setsuo
Mori, Yuka
Tanimoto, Kiyotaka
Mori, Yoshiro
Miyatake, Nobuyuki
AuthorAffiliation 1 Department of Hygiene, Faculty of Medicine, Kagawa University, Miki 761-0793, Japan; miyatake.nobuyuki@kagawa-u.ac.jp (N.M.); suzuki.hiromi@kagawa-u.ac.jp (H.S.)
2 Sakaide City Hospital, Sakaide 762-8550, Japan; hosp02@city.sakaide.lg.jp (S.O.); taka12ki05@gmail.com (K.T.)
3 Graduate School of Health Sciences, Tokushima University, Tokushima 770-8503, Japan; mogeko@hi.enjoy.ne.jp
AuthorAffiliation_xml – name: 2 Sakaide City Hospital, Sakaide 762-8550, Japan; hosp02@city.sakaide.lg.jp (S.O.); taka12ki05@gmail.com (K.T.)
– name: 3 Graduate School of Health Sciences, Tokushima University, Tokushima 770-8503, Japan; mogeko@hi.enjoy.ne.jp
– name: 1 Department of Hygiene, Faculty of Medicine, Kagawa University, Miki 761-0793, Japan; miyatake.nobuyuki@kagawa-u.ac.jp (N.M.); suzuki.hiromi@kagawa-u.ac.jp (H.S.)
Author_xml – sequence: 1
  fullname: Mori, Yoshiro
– sequence: 2
  fullname: Miyatake, Nobuyuki
– sequence: 3
  fullname: Suzuki, Hiromi
– sequence: 4
  fullname: Mori, Yuka
– sequence: 5
  fullname: Okada, Setsuo
– sequence: 6
  fullname: Tanimoto, Kiyotaka
BackLink https://cir.nii.ac.jp/crid/1873961342487667072$$DView record in CiNii
BookMark eNp9Ustv0zAYj9AQG2N3jpbgwCVgx4kfHJBGeVXaNKSViZvl2F9aV4ld7KRi_z1uOyTWA7bk1_d72P6-58WJDx6K4iXBbymV-N1WG-M8JIIxw6JhT4qzCnNWUkl_nvyzPi0uUlrj3CShgvFnxSlteM1yPyv09wjlfNhESMkFn1Do0LgCtFi5aNHs5m7-qSQS3e299JghSA_BL9E1WGd0j25H3XXv0SVawO8RXTvv_LL8qBNYdDvFLdy_KJ52uk9w8TCfFz--fF7MvpVXN1_ns8ur0jDMxrLDtRCSUYobCQIoYAttRyWvMJOsMa0BaKrW1oQx0hJqjbUS14xmbCsxo-fF_KBrg16rTXSDjvcqaKf2ByEulY6jMz0oCRaTSrdVxeu6a4loCKZWgK65bPIua304aG2mdgBrwI9R949EH0e8W6ll2CpZUczF7jJvHgRi-DVBGtXgkoG-1x7ClFTFRLbkTPIMfXUEXYcp-vxVGcVlTqxkOxQ7oEwMKUXolHHjPh_Z3_WKYLUrCnVcFJmIj4h_X_EfyusDxTuXbXYjEZxKRmhd1YIzxjGv6B92SsRw
CitedBy_id crossref_primary_10_7759_cureus_55861
crossref_primary_10_1111_cen3_70005
crossref_primary_10_3390_vaccines11081327
crossref_primary_10_1002_adhm_202304575
crossref_primary_10_1016_j_jvacx_2024_100480
crossref_primary_10_7759_cureus_72598
crossref_primary_10_1002_agm2_12329
crossref_primary_10_4103_jasi_jasi_83_23
crossref_primary_10_3390_tropicalmed7100298
Cites_doi 10.1126/science.abn7760
10.3390/pharmacy9040167
10.1016/S0140-6736(18)30854-7
10.3390/vaccines9111282
10.3390/vaccines9111358
10.1001/jama.2022.2274
10.3390/vaccines10010068
10.3390/vaccines9030200
10.3390/vaccines9111286
10.3390/vaccines9050469
10.1001/jama.2021.24315
10.3390/v13030371
10.1016/j.vaccine.2021.11.097
10.3390/vaccines9111295
10.1038/s41591-021-01459-7
10.1186/1471-2393-14-19
ContentType Journal Article
Copyright 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2022 by the authors. 2022
Copyright_xml – notice: 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2022 by the authors. 2022
DBID RYH
AAYXX
CITATION
3V.
7T7
7XB
8FD
8FE
8FH
8FK
8G5
ABUWG
AEUYN
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
C1K
CCPQU
COVID
DWQXO
FR3
GNUQQ
GUQSH
HCIFZ
LK8
M2O
M7P
MBDVC
P64
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOA
DOI 10.3390/vaccines10060856
DatabaseName CiNii Complete
CrossRef
ProQuest Central (Corporate)
Industrial and Applied Microbiology Abstracts (Microbiology A)
ProQuest Central (purchase pre-March 2016)
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Research Library
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
Coronavirus Research Database
ProQuest Central Korea
Engineering Research Database
ProQuest Central Student
ProQuest Research Library
SciTech Premium Collection
Biological Sciences
Research Library
Biological Science Database
Research Library (Corporate)
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
Publicly Available Content Database
Research Library Prep
ProQuest Central Student
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
Research Library (Alumni Edition)
ProQuest Natural Science Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Research Library
Industrial and Applied Microbiology Abstracts (Microbiology A)
ProQuest Central (New)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest One Academic Eastern Edition
Coronavirus Research Database
Biological Science Database
ProQuest SciTech Collection
Biotechnology and BioEngineering Abstracts
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
Publicly Available Content Database

CrossRef
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Pharmacy, Therapeutics, & Pharmacology
Public Health
EISSN 2076-393X
ExternalDocumentID oai_doaj_org_article_9ed012ab22744fb185103d8ea4795185
PMC9230786
10_3390_vaccines10060856
GeographicLocations Japan
GeographicLocations_xml – name: Japan
GroupedDBID 53G
5VS
8FE
8FH
8G5
AADQD
AAHBH
ABUWG
ADBBV
AEUYN
AFKRA
AFZYC
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
CCPQU
DIK
DWQXO
GNUQQ
GROUPED_DOAJ
GUQSH
HCIFZ
HYE
IAO
IHR
ITC
KQ8
LK8
M2O
M48
M7P
MODMG
M~E
OK1
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
RNS
RPM
RYH
AAYXX
CITATION
3V.
7T7
7XB
8FD
8FK
C1K
COVID
FR3
MBDVC
P64
PKEHL
PQEST
PQGLB
PQUKI
PRINS
Q9U
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c606t-f04889633059e8e3e0debf397206965cbcee52bd41661b13dcdd904638e3b9063
IEDL.DBID DOA
ISSN 2076-393X
IngestDate Wed Aug 27 01:31:50 EDT 2025
Thu Aug 21 18:19:59 EDT 2025
Fri Sep 05 07:39:24 EDT 2025
Fri Jul 25 11:57:09 EDT 2025
Thu Apr 24 23:01:47 EDT 2025
Tue Jul 01 02:25:09 EDT 2025
Thu Jun 26 23:48:46 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Language English
License https://creativecommons.org/licenses/by/4.0
Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c606t-f04889633059e8e3e0debf397206965cbcee52bd41661b13dcdd904638e3b9063
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://doaj.org/article/9ed012ab22744fb185103d8ea4795185
PMID 35746464
PQID 2679856967
PQPubID 2032320
ParticipantIDs doaj_primary_oai_doaj_org_article_9ed012ab22744fb185103d8ea4795185
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9230786
proquest_miscellaneous_2681037697
proquest_journals_2679856967
crossref_citationtrail_10_3390_vaccines10060856
crossref_primary_10_3390_vaccines10060856
nii_cinii_1873961342487667072
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20220526
PublicationDateYYYYMMDD 2022-05-26
PublicationDate_xml – month: 5
  year: 2022
  text: 20220526
  day: 26
PublicationDecade 2020
PublicationPlace Basel
PublicationPlace_xml – name: Basel
PublicationTitle Vaccines
PublicationYear 2022
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References Mannar (ref_2) 2022; 375
Omer (ref_3) 2022; 327
Lennon (ref_15) 2022; 40
Ulloa (ref_4) 2022; 327
ref_14
ref_13
ref_12
ref_23
ref_11
Higuchi (ref_21) 2017; 53
ref_10
ref_19
Machingaidze (ref_1) 2021; 27
ref_18
Corcoran (ref_22) 2018; 391
ref_17
ref_16
ref_9
Higuchi (ref_20) 2016; 52
ref_8
ref_5
ref_7
ref_6
References_xml – volume: 375
  start-page: 760
  year: 2022
  ident: ref_2
  article-title: SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein-ACE2 complex
  publication-title: Science
  doi: 10.1126/science.abn7760
– ident: ref_7
– ident: ref_6
– ident: ref_8
– ident: ref_11
  doi: 10.3390/pharmacy9040167
– volume: 391
  start-page: 2103
  year: 2018
  ident: ref_22
  article-title: Rapid response to HPV vaccination crisis in Ireland
  publication-title: Lancet
  doi: 10.1016/S0140-6736(18)30854-7
– ident: ref_9
  doi: 10.3390/vaccines9111282
– ident: ref_14
  doi: 10.3390/vaccines9111358
– ident: ref_5
– volume: 327
  start-page: 1286
  year: 2022
  ident: ref_4
  article-title: Estimates of SARS-CoV-2 Omicron Variant Severity in Ontario, Canada
  publication-title: JAMA
  doi: 10.1001/jama.2022.2274
– ident: ref_18
  doi: 10.3390/vaccines10010068
– ident: ref_12
  doi: 10.3390/vaccines9030200
– ident: ref_16
  doi: 10.3390/vaccines9111286
– ident: ref_10
  doi: 10.3390/vaccines9050469
– volume: 53
  start-page: 137
  year: 2017
  ident: ref_21
  article-title: A Two-Step Approach to Quantitative Content Analysis: KH Coder Tutorial Using Anne of Green Gables (Part II)
  publication-title: Ritsumeikan Soc. Sci. Rev.
– volume: 327
  start-page: 319
  year: 2022
  ident: ref_3
  article-title: Winter of Omicron-The Evolving COVID-19 Pandemic
  publication-title: JAMA
  doi: 10.1001/jama.2021.24315
– ident: ref_19
– ident: ref_13
  doi: 10.3390/v13030371
– volume: 40
  start-page: 562
  year: 2022
  ident: ref_15
  article-title: Underserved population acceptance of combination influenza-COVID-19 booster vaccines
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2021.11.097
– ident: ref_17
  doi: 10.3390/vaccines9111295
– volume: 27
  start-page: 1338
  year: 2021
  ident: ref_1
  article-title: Understanding COVID-19 vaccine hesitancy
  publication-title: Nat. Med.
  doi: 10.1038/s41591-021-01459-7
– volume: 52
  start-page: 77
  year: 2016
  ident: ref_20
  article-title: A Two-Step Approach to Quantitative Content Analysis: KH Coder Tutorial Using Anne of Green Gables (Part I)
  publication-title: Ritsumeikan Soc. Sci. Rev.
– ident: ref_23
  doi: 10.1186/1471-2393-14-19
SSID ssj0000913867
Score 2.2438185
Snippet The aim of this study was to investigate the pre-impressions of the third Coronavirus disease 2019 (COVID-19) vaccination among Japanese medical staff using...
SourceID doaj
pubmedcentral
proquest
crossref
nii
SourceType Open Website
Open Access Repository
Aggregation Database
Enrichment Source
Index Database
Publisher
StartPage 856
SubjectTerms Age groups
Communication
Coronaviruses
COVID-19
COVID-19 vaccines
Data mining
Disease transmission
Hospitals
Influenza
Job titles
Medical personnel
Medicine
Nurses
Pregnancy
Public health
Questionnaires
R
Side effects
Software
text-mining
third COVID-19 vaccination
Underserved populations
Vaccination
Viral diseases
SummonAdditionalLinks – databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9swED-69mUwxtZtzGs7NBiFQUX8KUuDMZqupRs0C1ta-mYkS-4Cw26dpJD_fne2k9R76EseYjlxcl-_k-5-B_DRGF1oKzSXoY14nNiCm8BQZY5JZK5iqzRtDVyMxPll_OM6ud6C0aoXhsoqVz6xcdS2ymmPfBDScUEilEi_3t5xmhpFp6urERq6G61gvzQUY09gB12yRL3fGZ6Oxr_Wuy7EgilF2p5XRpjvD-7xViowD4iZRNIc6wfxqaHxx6hTTqc9BNqvn3wQkM5ewPMOSbLjVvQvYcuVu3A4bqmol0dssumsmh2xQzbekFQvd-FZu1_H2jakV6DHteO0w9DydMxYVTDEhvgp09qyk59X37_xQLGr5nc00mTNnCLWnfQwmgNcfGbHbILunl00cyf4EGOkZb8X9b1bvobLs9PJyTnvxi_wHLOaOS_IuNE-0SMoJ13kfOtMgfgl9FEMSW4wviahsQjpRGCCyObWKiIgw7VGIfR5A9tlVbq3wAIXpkpjLpwaaqyVEr1qkWhpcoQXUSw9GKz-9CzvuMlpRMbfDHMUElP2v5g8-LS-47bl5Xhk7ZDkuF5HjNrNG1V9k3UGmilnMVZrExJlYmEQxgR-ZKXTcYogVCYeHKAW4NPRayDTSCEQikPM94RI_TT0YH-lH1nnBmbZRmk9-LC-jAZMpzK6dNWC1kjq1RQK16Q9veo9cP9KOf3TUIErquOX4t3jX74HT0Pq2vCpoHEftuf1wh0glpqb952B_APwAB23
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Open Access Journals
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3fb9MwELZgvPCCYIDI2JAnoUlIM0uc2LGR0LQfTAOpUIl22ltkxw5UmlJI24n-99w5aUvQxBMvfUjOkuvz-b7L-b4j5LW1pjJOGqa4S1kmXMVsYvFmjhWq1JnTBj8NDD7Ly3H26Vpcb8qjuwWc3RnaYT-pcXPz9tfP5TEY_HuMOCFkP7o1JSahZwmSiygh75MH4JckhmKDDuyHc1knqZJ5m6u8c2DPNwUKf_A49WTSQ5_9u5N_OKOLx-RRhyLpSav2J-Ser7fJwbCloV4e0tGmqmp2SA_ocENQvXxKzLDxDL8mtJwcMzqtKOBAGDVpHD37cvXxnCWaXoV5B83R0JOIdlkdij1_q3f0hI7gaKeD0GOCnYI_dPTrorn1y2dkfPFhdHbJulYLrIQIZs4qNGSwRbB-7ZVPfey8rQCr8FhqKUoLvlRw62BZZWKT1JXOaSQbA1mrAeY8J1v1tPYvCE08z7WBuDe3WESrFJyglTDKlgAl0kxF5Gi1yEXZ8ZBjO4ybAuIRVEvxt1oi8mY94kfLwfEP2VPU21oO2bPDg2nzreiMsdDegV82liM9YmUBsiRx6pQ3WQ6AU4mI7IHWYXb4m6g81QB6Mg6xnZR5nPOI7K72Q7HasQXHfJaA1cojsr9-DcaKGRhT--kCZRTWZUoNMnlvH_Um3H9TT74H2m-Nd_aV3Pkf__AlecixjiPGK467ZGveLPweoKu5fRWM5jeoKCLH
  priority: 102
  providerName: Scholars Portal
Title Pre-Impressions of the Third COVID-19 Vaccination among Medical Staff: A Text Mining-Based Survey
URI https://cir.nii.ac.jp/crid/1873961342487667072
https://www.proquest.com/docview/2679856967
https://www.proquest.com/docview/2681037697
https://pubmed.ncbi.nlm.nih.gov/PMC9230786
https://doaj.org/article/9ed012ab22744fb185103d8ea4795185
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYlveRS-kip2ySoEAKFiLVkW4_esmlCWth0aTchNyNZMlko3rKPwP77zsjOZt1De8nFB1sGWTOj-cYz-oaQI-dsbb20TAufsbzwNXPcYWWOK3Rlcm8s_hoYXcnL6_zbbXG71eoLa8JaeuB24QYmeNhDrRNIZVc7cC88zbwONlcADnRkL01NuhVMxT3Y8ExL1eYlM4jrB_e2wkz1giMDicZ-1Vt-KNL1g3dpptMe0uzXSW45nouX5EWHGOlpO9NX5FloXpPjcUs5vT6hk8cTVIsTekzHj2TU6zfEjueB4Z-Dln9jQWc1BcwHb03nnp59v_n6hXFDb-K8o5Ro7D9EuwwOxf6-9Wd6SiewjdNR7CfBhuD7PP25mt-H9R65vjifnF2yrq0CqyBaWbIajRbsDizdBB2ykPrgasAlIpVGFpUDv1kI5wGqSe545ivvDRKLwVhnANK8JTvNrAnvCOVBKGMhxlUOD8xqDbtlXVjtKoANWa4TMnhY5LLqOMex9cWvEmIPFEv5t1gS8mnzxu-Wb-MfY4cot804ZMqON0B_yk5_yv_pT0IOQOowO7xyrTIDACcXEMdJqVIlErL_oA9lZ96LUmDuqoDVUgn5uHkMhonZFtuE2QrHaDyDKQ2MUT096k24_6SZ3kWKb4P1-Vq-f4ov_EB2BZ7ZSLGccZ_sLOercABIaukOyfPh-dX4x2E0HriOcv0HDFMb5Q
linkProvider Directory of Open Access Journals
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6V9AASQlBAGFpYJKiEVCv2-rWLVKGmDyW0CRGkVW9m17uGSMgpeRTlz_HbmLGdpOHQWy85xBt7nZmd-XZn5huAd1qrXJlYuYKbwA0jk7va15SZoyORydBIRUcD3V7cPg8_X0aXG_B3UQtDaZULm1gaajPK6Iy8ySlcEMUyTj5d_XapaxRFVxctNFTdWsHslxRjdWHHqZ3_wS3cZL9zhPJ-z_nJ8eCw7dZdBtwMwfvUzUmHUQ1R8aUVNrCesTpHN809fFqUaXQjEdcGkUvsaz8wmTGSeLZwrJbo4fG-92AzpArXBmy2jnv9r8tTHmLdFHFSxUeDQHrNa5wqJbT7xIQiqG_2DX9Ytg1AL1cMh2uIdz1f84YDPHkMj2rkyg4qVXsCG7bYgt1-RX0932ODVSXXZI_tsv6KFHu-BQ-r80FWlT09BdUfW5dONCpekAkb5QyxKN5lODbs8MtF58j1Jbso36PUHlb2RWJ1ZIlR3-H8IztgA3QvrFv2uXBb6JMN-zYbX9v5Mzi_E0E8h0YxKuwLYL7liVS49040FfIKgVY8j5TQGcKZIBQONBd_eprVXOjUkuNXinsiElP6v5gc-LD8xVXFA3LL2BbJcTmOGLzLL0bjH2ltEFJpDWIDpTlRNOYaYZPvBUZYFSYIekXkwA5qAc6OPn2RBBKBV8hxfxnHiZdwB7YX-pHWZmeSrhaJA2-Xl9FgUBRIFXY0ozGCakNjiWOSNb1am_D6lWL4s6Qel1Q3IOKXtz_8DdxvD7pn6Vmnd_oKHnCqGPEomXIbGtPxzO4gjpvq1_ViYfD9rtfnPz2FWcg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NTkJICMEALbCBkWAS0qImzpeNNKF1XbUyViropr0FO3agEkpHP4b6L_JXcZek7crD3vbSh8ZNnN757mff3e8A3mqtcmVi5QpuAjeMTO5qX1Nmjo5EJkMjFR0NnPXik_Pw02V0uQF_F7UwlFa5sImloTajjM7Im5zCBVEs46SZ12kR_Xbn49VvlzpIUaR10U5D1W0WzEFJN1YXeZza-R_czk0Oum2U_TvOO8eDoxO37jjgZgjkp25O-owqiYtAWmED6xmrc3TZ3MMnR5lGlxJxbRDFxL72A5MZI4lzC8dqid4e73sPNhP0kmEDNlvHvf7X5YkPMXCKOKlipUEgveY1TpWS231iRRHUQ_uGbyxbCKDHK4bDNfS7nrt5wxl2HsOjGsWyw0rtnsCGLbZgr1_RYM_32WBV1TXZZ3usvyLInm_Bw-qskFUlUE9B9cfWpdONiiNkwkY5Q1yKdxmODTv6ctFtu75kF-V7lJrEyh5JrI4yMepBnH9gh2yA8mJnZc8Lt4X-2bBvs_G1nT-D8zsRxHNoFKPCbgPzLU-kwn14oqmoVwi06HmkhM4Q2gShcKC5-NPTrOZFp_Ycv1LcH5GY0v_F5MD75S-uKk6QW8a2SI7LccTmXX4xGv9Ia-OQSmsQJyjNia4x1wihfC8wwqowQQAsIgd2UQtwdvTpiySQCMJCjnvNOE68hDuws9CPtDZBk3S1YBx4s7yMxoMiQqqwoxmNEVQnGksck6zp1dqE168Uw58lDbmkGgIRv7j94a_hPq7T9HO3d_oSHnAqHvEor3IHGtPxzO4ipJvqV_VaYfD9rpfnP1O0XfQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pre-Impressions+of+the+Third+COVID-19+Vaccination+among+Medical+Staff%3A+A+Text+Mining-Based+Survey&rft.jtitle=Vaccines+%28Basel%29&rft.au=Yoshiro+Mori&rft.au=Nobuyuki+Miyatake&rft.au=Hiromi+Suzuki&rft.au=Yuka+Mori&rft.date=2022-05-26&rft.pub=MDPI+AG&rft.eissn=2076-393X&rft.volume=10&rft.issue=6&rft.spage=856&rft_id=info:doi/10.3390%2Fvaccines10060856&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_9ed012ab22744fb185103d8ea4795185
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2076-393X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2076-393X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2076-393X&client=summon